Tryp Therapeutics Inc.
Tryp Therapeutics Inc. (TRYP.CN) Stock Overview
Explore Tryp Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
5.8M
P/E Ratio
-1.10
EPS (TTM)
$-0.04
ROE
4.03%
TRYP.CN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Tryp Therapeutics Inc. (TRYP.CN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.01.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.10 and a market capitalization of 5.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.